Brandi Hilder
- Hematology top 1%
- Oncology top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology
- Co-authors
- Niels W.C.J. van de DonkPaula Rodríguez‐OteroMonique C. MinnemaAjai ChariMaría‐Victoria MateosRaluca VeronaAmrita KrishnanAlbert Oriol
- Topics
- Multiple Myeloma Research and Treatments (41 papers)Monoclonal and Polyclonal Antibodies Research (21 papers)Protein Degradation and Inhibitors (15 papers)
- Partner nations
- United StatesNetherlandsSpain
In The Last Decade
Brandi Hilder
40 papers receiving 963 citations
Hit Papers
Peers
Comparison fields: 5 of 46
- Hematology 674
- Oncology 593
- Molecular Biology 517
- Radiology, Nuclear Medicine and Imaging 295
- Immunology 154
Countries citing papers authored by Brandi Hilder
This map shows the geographic impact of Brandi Hilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandi Hilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandi Hilder more than expected).
Fields of papers citing papers by Brandi Hilder
This network shows the impact of papers produced by Brandi Hilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandi Hilder. The network helps show where Brandi Hilder may publish in the future.
Co-authorship network of co-authors of Brandi Hilder
This figure shows the co-authorship network connecting the top 25 collaborators of Brandi Hilder. A scholar is included among the top collaborators of Brandi Hilder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandi Hilder. Brandi Hilder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | GPRC5D as a novel target for the treatment of multiple myeloma: a narrative reviewbreakdown → | 51 |
| 7 | 19 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 5 | |
| 11 | 29 | |
| 12 | 30 | |
| 13 | 10 | |
| 14 | 40 | |
| 15 | 48 | |
| 16 | 2 | |
| 17 | 13 | |
| 18 | 26 | |
| 19 | 4 | |
| 20 | 9 |
About Brandi Hilder
Brandi Hilder is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 43 papers that have together received 978 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (41 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Protein Degradation and Inhibitors (15 papers). The work is most often cited by research in Hematology (674 citations), Oncology (593 citations) and Radiology, Nuclear Medicine and Imaging (295 citations). Brandi Hilder has collaborated with scholars based in United States, Netherlands and Spain. Frequent co-authors include Niels W.C.J. van de Donk, Paula Rodríguez‐Otero, Monique C. Minnema, Ajai Chari, María‐Victoria Mateos, Raluca Verona, Amrita Krishnan, Albert Oriol, Suzette Girgis and Jesús G. Berdeja. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.